Randomized, controlled, open label, phase 2 clinical trial of Interferon-ß-1a (IFNß-1a) in COVID-19 patients.
Latest Information Update: 30 Aug 2021
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications COVID 2019 infections; COVID-19 pneumonia
- Focus Therapeutic Use
- 29 Aug 2021 Status changed from recruiting to discontinued.
- 14 Aug 2020 New trial record